Abstract
Phase II clinical trials play a pivotal role in drug development by screening a large number of drug candidates to identify those with promising preliminary efficacy for phase III testing. Trial designs that enable efficient decision-making with small sample sizes and early futility stopping while controlling for type I and II errors in hypothesis testing, such as Simon’s two-stage design, are preferred. Randomized multi-arm trials are increasingly used in phase II settings to overcome the limitations associated with using historical controls as the reference. However, how to effectively balance efficiency and accurate decision-making continues to be an important research topic. A notable development in phase II randomized design methodology is the Bayesian pick-the-winner (BPW) design that extends a Simon’s two-stage based multi-arm design with a Bayesian winner-selection strategy. Despite multiple appealing features, this method cannot easily control for overall type I and II errors for winner selection. Here, we introduce an improved randomized two-stage Bayesian pick-the-winner (IBPW) design that formalizes the winner-selection based hypothesis testing, optimizes sample sizes and decision cut-offs by strictly controlling the type I and type II errors under a set of flexible hypotheses for winner-selection across two treatment arms. Simulation studies demonstrate that our new design offers improved operating characteristics for winner selection while retaining the desirable features of the BPW design.
Disciplines
Applied Statistics | Biostatistics | Clinical Trials | Statistical Methodology
Suggested Citation
Lei, Wanni; Peng, Maosen; and Zhou, Xi K., "An improved Bayesian pick-the-winner (IBPW) design for randomized phase II clinical trials" (May 2024). COBRA Preprint Series. Working Paper 122.
https://biostats.bepress.com/cobra/art122
Included in
Applied Statistics Commons, Biostatistics Commons, Clinical Trials Commons, Statistical Methodology Commons